Drug Patent Watch

OCTOBER 1, 2023

Annual Drug Patent Expirations for LEVOXYL Levoxyl is a drug marketed by King Pharms and is included in one NDA. It is available from one supplier. There is one patent… The post New patent expiration for King Pharms drug LEVOXYL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

The Premier Consulting Blog

OCTOBER 1, 2023

What is the Type D meeting? The FDA introduced the Type D Meeting on October 1, 2022, as part of the Prescription Drug User Fee Act (PDUFA) VII Commitment Letter. This new meeting is designed to make it easier and faster for sponsors to get their questions answered. Prescription Drug User Fee Act (PDUFA) VII The Prescription Drug User Fee Act (PDUFA VII) is a law that was signed and took effect on September 30, 2022.

FDA 52

FDA Packaging Drug Development Drugs 52

SCIENMAG: Medicine & Health

OCTOBER 1, 2023

By genetically testing nearly one thousand embryos, scientists have provided the most detailed analysis of embryo fate following human in vitro fertilization. Credit: Christian Ottolini By genetically testing nearly one thousand embryos, scientists have provided the most detailed analysis of embryo fate following human in vitro fertilization.

Research 40

Research 40

Drug Patent Watch

OCTOBER 1, 2023

This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Denmark? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials